- Sep 13
USC study identifies new risk factor for most common childhood cancer, Acute Lymphoblastic Leukemia
According the research, children genetically predisposed to overproduce lymphocytes in relation to other white blood cells are at...
- Aug 11
Pediatric ALL Relapse May Be Caused by Mutations From Chemotherapy
Chemotherapy is standard care for pediatric acute lymphoblastic leukemia (ALL), but new research shows thiopurines can cause mutations ...
- Jul 30
International Collaboration Helps Refine Treatment for Childhood Leukemia
Scientists at St. Jude Children’s Research Hospital are working with colleagues in China to develop better therapy for childhood acute...
- Jul 2
FDA Approves Rylaze as Alternative for Patients with ALL and Lymphoblastic Lymphoma
New FDA approval means that pediatric and adult patients with acute lymphoblastic leukemia (ALL) and lympoblastic lymphoma who are...
- Jun 16
Clinical Challenges: Pediatric ALL in Children With Obesity
Although obesity has been strongly linked to 13 cancers in adults, and is suspected as a risk factor in many hematologic malignancies, ...
- Jun 1
New drug combo found effective against high-risk leukaemia
Australian scientists have found what could prove to be a new and effective way to treat a particularly aggressive blood cancer in ...
- Apr 6
Low-calorie diet and mild exercise improve survival for young people with leukemia
Now, a study led by researchers at UCLA and Children's Hospital Los Angeles has shown that a combination of modest dietary changes and...
- Apr 5
Study: Stem Cell Transplants Prevent Relapses of Most Common Childhood Cancer
Children and young adults who receive CAR T-cell therapy for the most common childhood cancer, acute lymphoblastic leukemia, suffer...
- Dec 14, 2020
Radiation Therapy for Childhood Leukemia Alters BMI Heritability, Study Finds
Adult survivors of childhood acute lymphoblastic leukemia (ALL), who are at high risk for obesity, exhibit alterations in genetic...
- Nov 3, 2020
Reduced-intensity therapy effective for children with very low-risk ALL
Children with very low-risk acute lymphoblastic leukemia can be treated successfully with reduced-intensity therapy, according to ...